Product logins

Find logins to all Clarivate products below.


Open Surgery Instruments | Medtech 360 | Market Analysis | Asia Pacific (Supplemental) | 2017

The Asia Pacific open surgery instrument market will grow rapidly through 2025. Emerging economies will be major centers of growth due to their improving health care infrastructure and promising economic and demographic landscapes. Additionally, the mature markets will grow, primarily as a result of demand for innovative and premium-priced products, especially in the direct energy device segment.

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the open surgery instruments market in Asia Pacific, including country-level data for 13 major countries and aggregate data for the rest of Asia Pacific, across a 10-year period.

Related Medtech Insights Reports

Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…
Report
Trauma Devices – Market Insights – Asia Pacific
The Asia Pacific trauma device market is experiencing steady growth driven by a rising incidence of fractures, an aging population, and increasing rates of road traffic accidents, particularly in…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – Asia Pacific
The Asia Pacific TEO device market will experience steady growth over the forecast period, driven by rising cancer incidence, increasing preference for minimally invasive procedures, and clinical…